Search
12/04/2025
Sex-based differences in Jumping to Conclusions: a multidimensional analysis of first-episode psychosis
Díaz-Cutraro, L, Verdaguer-Rodríguez, M, García-Mieres, H, Ferrer-Quintero, M, López-Carrilero, R, Palma-Sevillano, C, Lamarca, M, Espinosa, V, Barrigón, ML, González-Higueras, F, Pousa, E, Grasa, E, Lorente-Rovira, E, Gutiérrez-Zotes, A, Barajas, A, Ruiz-Delgado, I, Cid, J, Moritz, S, Rico, J, Sevilla-Llewellyn-Jones, J, Haro, JM, Ochoa, S. Sex-based differences in Jumping to Conclusions: a multidimensional analysis of first-episode psychosis. SCHIZOPHRENIA. 2025; 11(1)DOI:10.1038/s41537-025-00579-0. PMID:40221473. IF:4.100(Q1/2D).
10/04/2025
Dapagliflozin in Patients Undergoing Transcatheter Aortic-Valve Implantation
Raposeiras-Roubin, S, Amat-Santos, IJ, Rossello, X, Ferreiro, RG, Bermúdez, IG, Otero, DL, Nombela-Franco, L, Gheorghe, L, Diez, JL, Zorita, CB, Baz, JA, García, AJM, Vilalta, V, Ojeda-Pineda, S, Hernández, JMD, Soriano, JGC, Regueiro, A, Siscar, PB, Fernández, JS, del Blanco, BG, Martín-Reyes, R, Romaguera, R, Moris, C, Blas, SG, Franco-Peláez, JA, Cruz-González, I, Arzamendi, D, Rodríguez, NR, Hoyo, FDD, Freire, SC, Ojeda, FB, Burgo, JCA, Navarro, EM, Borrego, JC, Quevedo, VR, Sánchez-Recalde, A, Disdier, VP, Alegría-Barrero, E, Torres-Llergo, J, Feltes, G, Díaz, JAF, Cuellas, C, Britez, GJ, Lezcano, JSR, Barreiro-Pardal, C, Núñez-Gil, I, Abu-Assi, E, Iñiguez-Romo, A, Fuster, V, Ibáñez, B. Dapagliflozin in Patients Undergoing Transcatheter Aortic-Valve Implantation. NEW ENGLAND JOURNAL OF MEDICINE. 2025; 392(14)DOI:10.1056/NEJMoa2500366. PMID:40162639. IF:78.500(Q1/1D).
09/04/2025
Pediatric densitometry: is the Z score adjustment necessary in all cases?
Magallares, B, Malouf, J, Codes-Méndez, H, Park, HS, Betancourt, J, Fraga, G, Quesada-Masachs, E, López-Corbeto, M, Torrent, M, Marin, A, Herrera, S, Gich, I, Boronat, S, Casademont, J, Corominas, H, Cerdá, D. Pediatric densitometry: is the Z score adjustment necessary in all cases?. Frontiers in Endocrinology. 2025; 16DOI:10.3389/fendo.2025.1587382. PMID:40270717. IF:4.600(Q1/3D).
09/04/2025
Preeclampsia as an independent predictor of atherosclerosis progression in women with type 1 diabetes: a 5-year prospective study
Mesa, A, Puig-Jove, C, Pané, A, Vinagre, I, López-Quesada, E, Meler, E, Alonso-Carril, N, Quirós, C, Amor, AJ, Perea, V. Preeclampsia as an independent predictor of atherosclerosis progression in women with type 1 diabetes: a 5-year prospective study. Cardiovascular Diabetology. 2025; 24(1)DOI:10.1186/s12933-025-02719-3. PMID:40205402. IF:10.600(Q1/1D).
08/04/2025
To Kill Time: A Bold Step Toward Simplifying Multiple Sclerosis Diagnosis
Vidal-Jordana, A, Ontaneda, D. To Kill Time: A Bold Step Toward Simplifying Multiple Sclerosis Diagnosis. NEUROLOGY. 2025; 104(7)DOI:10.1212/WNL.0000000000213416. PMID:40036710. IF:8.500(Q1/1D).
05/04/2025
Advancing Personalized Medicine in Alzheimer's Disease: Liquid Biopsy Epigenomics Unveil APOE e4-Linked Methylation Signatures
Macías, M, Alba-Linares, JJ, Acha, B, Blanco-Luquin, I, Fernández, AF, Alvarez-Jiménez, J, Urdánoz-Casado, A, Roldan, M, Robles, M, Cabezon-Arteta, E, Alcolea, D, de Gordoa, JSR, Corroza, J, Cabello, C, Erro, ME, Jericó, I, Fraga, MF, Mendioroz, M. Advancing Personalized Medicine in Alzheimer's Disease: Liquid Biopsy Epigenomics Unveil APOE e4-Linked Methylation Signatures. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2025; 26(7)DOI:10.3390/ijms26073419. PMID:40244264. IF:4.900(Q1/3D).
04/04/2025
Design and Validation of a Simplified Method to Determine Minimum Bactericidal Concentration in Nontuberculous Mycobacteria
Batista, S, Fernandez-Pittol, M, San Nicolás, L, Martínez, D, Narváez, S, Espasa, M, Losilla, EG, Rubio, M, Garrigo, M, Tudó, G, González-Martin, J. Design and Validation of a Simplified Method to Determine Minimum Bactericidal Concentration in Nontuberculous Mycobacteria. Antibiotics-Basel. 2025; 14(4)DOI:10.3390/antibiotics14040381. PMID:40298560. IF:4.600(Q1/2D).
03/04/2025
OCTA and Microperimetry Changes Preceding the Appearance of Diabetic Retinopathy in Patients with Type 1 Diabetes
Rego-Lorca, D, Mateu-Salat, M, Chico, A, Molina-Montero, A, Díaz-Cascajosa, J, Vela-Segarra, JI. OCTA and Microperimetry Changes Preceding the Appearance of Diabetic Retinopathy in Patients with Type 1 Diabetes. CURRENT EYE RESEARCH. 2025; 50(4)DOI:10.1080/02713683.2024.2435357. PMID:39637437. IF:2.000(Q2/5D).
03/04/2025
HDL-Cholesterol and Triglycerides Dynamics: Essential Players in Metabolic Syndrome
Alcover, S, Ramos-Regalado, L, Girón, G, Muñoz-García, N, Vilahur, G. HDL-Cholesterol and Triglycerides Dynamics: Essential Players in Metabolic Syndrome. Antioxidants. 2025; 14(4)DOI:10.3390/antiox14040434. PMID:40298782. IF:6.600(Q1/1D).
02/04/2025
Lipidomic analysis reveals metabolism alteration associated with subclinical carotid atherosclerosis in type 2 diabetes
Barranco-Altirriba, M, Rossell, J, Alonso, N, Weber, RJM, Ortega, E, Lloyd, GR, Hernandez, M, Yanes, O, Capellades, J, Winder, C, Junza, A, Falguera, M, Franch-Nadal, J, Dunn, WB, Perera-Lluna, A, Castelblanco, E, Mauricio, D. Lipidomic analysis reveals metabolism alteration associated with subclinical carotid atherosclerosis in type 2 diabetes. Cardiovascular Diabetology. 2025; 24(1)DOI:10.1186/s12933-025-02701-z. PMID:40176064. IF:10.600(Q1/1D).
01/04/2025
Rationale and Design of the Statin Use in Intracerebral Hemorrhage Patients (SATURN) Trial
Marchina, S, Yeatts, SD, Foster, LD, Janis, S, Shoamanesh, A, Khatri, P, Bernstein, K, Perlmutter, A, Stever, C, Heistand, EC, Broderick, JP, Greenberg, SM, Leira, EC, Rosand, J, Lioutas, VA, Salman, RA, Tirschwell, D, Marti-Fabregas, J, Selim, M. Rationale and Design of the Statin Use in Intracerebral Hemorrhage Patients (SATURN) Trial. CEREBROVASCULAR DISEASES. 2025; 54(2)DOI:10.1159/000538195. PMID:38493765. IF:1.500(Q3/8D).
01/04/2025
Comparison of clinical measures of motor function with a Holter monitor in Parkinson's disease
Pérez-López, C, Caballol, N, Buongiorno, M, Rivera, MAA, Ariztegui, NL, López-Manzanares, L, Hernández-Vara, J, Rusiñol, AB, Carreró, AG, Saúco, MA, Gomez, EF, Pérez-Martínez, DA, Arroyo, SE, Martínez, SM, Mir, P, Juan, JMS, Martínez-Castrillo, JC, Rodríguez-Molinero, A. Comparison of clinical measures of motor function with a Holter monitor in Parkinson's disease. Clinical Parkinsonism & Related Disorders. 2025; 12DOI:10.1016/j.prdoa.2025.100325. PMID:40329979. IF:(Q/D).
01/04/2025
Safety, Tolerability and Pharmacokinetics of Sodium Tungstate (OXO-001) in Healthy Female Volunteers of Childbearing Age: A Randomized, Double-Blind, Dose-Finding, and Placebo-Controlled Phase I Study
Arbat, A, Canals, I, Coimbra, J, Molina-Perelló, P, Llorens, M, Torres, R, Perello, J, Moral-Blanch, M, Antonijoan, RM, Calaf, J. Safety, Tolerability and Pharmacokinetics of Sodium Tungstate (OXO-001) in Healthy Female Volunteers of Childbearing Age: A Randomized, Double-Blind, Dose-Finding, and Placebo-Controlled Phase I Study. International Journal of Fertility & Sterility. 2025; 19(2)DOI:10.22074/ijfs.2024.2013704.1554. PMID:40200776. IF:0.471(Q4/10D).
01/04/2025
Neuropsychological profiles in first-episodes psychosis and their relationship with clinical, metacognition and social cognition variables
Espinosa, V, Bagaeva, A, Lopez-Carrilero, R, Barajas, A, Barrigón, ML, Birulés, I, Frigola-Capell, E, Díaz-Cutraro, L, González-Higueras, F, Grasa, E, Gutiérrez-Zotes, A, Lorente-Rovira, E, Pélaez, T, Pousa, E, Ruiz-Delgado, I, Verdaguer-Rodríguez, M, Ochoa, S. Neuropsychological profiles in first-episodes psychosis and their relationship with clinical, metacognition and social cognition variables. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE. 2025; 275(3)DOI:10.1007/s00406-024-01813-z. PMID:38806850. IF:3.700(Q1/3D).
01/04/2025
Scale to measure dialectical thinking from dialectical behavior therapy perspective.
Soler, J, Arqueros, M, Schmidt, C, Otero, D, Soria-Madrid, A, Campins, MJ, Catalan, A, Casellas, E, Espeso, R, Pascual, JC. Scale to measure dialectical thinking from dialectical behavior therapy perspective.. EUROPEAN JOURNAL OF PSYCHIATRY. 2025; 39(2)DOI:10.1016/j.ejpsy.2025.100305. PMID:. IF:1.500(Q3/7D).
01/04/2025
Alcohol and Other Substance Screening in Bariatric Surgery Candidates: Utility of Self-Report and Toxicology Tests, Including Ethyl-Glucoronide
Cañizares, S, Nuño, L, Barrio, P, Forner-Puntonet, M, Gavotti, C, Monràs, M, Gavín, P, Navinés, R, Flores, L, Barrios, M, Andreu, A, Molero, J, Jimenez, A, Vidal, J, Lligoña, A. Alcohol and Other Substance Screening in Bariatric Surgery Candidates: Utility of Self-Report and Toxicology Tests, Including Ethyl-Glucoronide. OBESITY SURGERY. 2025; 35(4)DOI:10.1007/s11695-025-07774-z. PMID:40072740. IF:3.100(Q1/2D).
01/04/2025
Early automated cerebral edema assessment following endovascular therapy: impact on stroke outcome
Guasch-Jiménez, M, Dhar, R, Kumar, A, Cifarelli, J, Ezcurra-Díaz, G, Lambea-Gil, A, Ramos-Pachón, A, Martínez-Domeño, A, Prats-Sánchez, L, Guisado-Alonso, D, Fernández-Cadenas, I, Aguilera-Simón, A, Marín, R, Martínez-González, J, Ortega-Quintanilla, J, Fernández-Pérez,I, Avellaneda-Gómez, C, Rodríguez-Pardo, J, de Celis, E, Moniche, F, Freijo, M, Cortijo, E, Trillo, S, Camps-Renom, P, Martí-Fábregas , J. Early automated cerebral edema assessment following endovascular therapy: impact on stroke outcome. Journal of NeuroInterventional Surgery. 2025; 17(4)DOI:10.1136/jnis-2024-021641. PMID:38637151. IF:4.300(Q1/1D).
01/04/2025
Clinical Spectrum and Prognosis of Atypical Autosomal Dominant Polycystic Kidney Disease Caused by Monoallelic Pathogenic Variants of IFT140
Zagorec, N, Calamel, A, Delaporte, M, Olinger, E, Orr, S, Sayer, JA, Pillay, VG, Denommé-Pichon, AS, Mau-Them, FT, Nambot, S, Faivre, L, Ars, E, Torra, R, Ong, ACM, Devuyst, O, Perico, N, Després, AM, Lemoine, H, de Fallois, J, Brousse, R, Hummel, A, Knebelmann, B, Maisonneuve, N, Halbritter, J, Le Meur, Y, Audrézet, MP, Cornec-Le Gall, E. Clinical Spectrum and Prognosis of Atypical Autosomal Dominant Polycystic Kidney Disease Caused by Monoallelic Pathogenic Variants of IFT140. AMERICAN JOURNAL OF KIDNEY DISEASES. 2025; 85(4)DOI:10.1053/j.ajkd.2024.10.009. PMID:39732359. IF:8.200(Q1/1D).
01/04/2025
Long-Term Outcomes of Rituximab-Treated Adult Patients with Podocytopathies
Gauckler, P, Matyjek, A, Kapsia, S, Marinaki, S, Quintana, LF, Diaz, MM, King, C, Griffin, S, Ramachandran, R, Odler, B, Eller, K, Artan, AS, Mirioglu, S, Busch, M, Schaepe, M, Turkmen, K, Cheung, CK, Pepper, RJ, Juarez, GF, Pascual, J, Aunon, P, García-Carro, C, Rodriguez, A, Alberici, F, Luzardo, L, Chebotareva, N, Schönermarck, U, Fernández, L, Radhakrishnan, J, Guaman, K, Peleg, Y, Hoisnard, L, Audard, V, Papasotiriou, M, Krnanska, N, Tesar, V, Hruskova, Z, Bruchfeld, A, Stangou, M, Lioulios, G, Faguer, S, Ribes, D, Salhi, S, Windpessl, M, Galesic, K, Crnogorac, M, Zagorec, N, Mayer, G, Kronbichler, A. Long-Term Outcomes of Rituximab-Treated Adult Patients with Podocytopathies. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2025; 36(4)DOI:10.1681/ASN.0000000520. PMID:39431468. IF:9.400(Q1/1D).
01/04/2025
N-terminal pro B-type natriuretic peptide as biomarker to predict pre-eclampsia and maternal-fetal complications
Nan, MN, Garrido-Giménez, C, Garcia-Osuna, A, Manau, PG, Ullmo, J, Mora, J, Sanchez-Garcia, O, Platero, J, Cruz-Lemini, M, Llurba, E. N-terminal pro B-type natriuretic peptide as biomarker to predict pre-eclampsia and maternal-fetal complications. ULTRASOUND IN OBSTETRICS & GYNECOLOGY. 2025; 65(4)DOI:10.1002/uog.29202. PMID:40088200. IF:6.300(Q1/1D).